Publications by authors named "Ronni Wasmuth"

Claim this Profile
C
CD37 in acute myeloid leukemia: a novel surface target for drug delivery.
Erin Jeremy, Esthela Artiga, Sara Elgamal, Carolyn Cheney, Dalen Eicher, Ronni Wasmuth

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.
Timothy L Chen, Bonnie Harrington, Jean Truxall, Ronni Wasmuth, Alexander Prouty

J Hematol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemia.
Lindsey T Brinton, Pu Zhang, Katie Williams, Daniel Canfield, Shelley Orwick, Ronni Wasmuth

J Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
Rajeswaran Mani, Girish Rajgolikar, Jessica Nunes, Kevan Zapolnik, Ronni Wasmuth

Cytotherapy· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia.
Lindsey T Brinton, Steven Sher, Katie Williams, Daniel Canfield, Shelley Orwick, Ronni Wasmuth

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia.
Ola A Elgamal, Abeera Mehmood, Jae Yoon Jeon, Bridget Carmichael, Amy Lehman, Ronni Wasmuth

J Hematol Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell Lymphoma.
Fabienne Lucas, Kerry A Rogers, Bonnie K Harrington, Alexander Pan, Lianbo Yu, Ronni Wasmuth

Clin Cancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.
J T Greene, Rajeswaran Mani, Rahul Ramaswamy, Frank Frissora, Max Yano, Ronni Wasmuth

Blood Adv· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib.
Emily M McWilliams, Christopher R Lucas, Timothy Chen, Bonnie K Harrington, Ronni Wasmuth

Blood Adv· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression.
Shuai Dong, Bonnie K Harrington, Eileen Y Hu, Joseph T Greene, Amy M Lehman, Ronni L Wasmuth

J Clin Invest· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34CD123 cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors.
Rajeswaran Mani, Swagata Goswami, Bhavani Gopalakrishnan, Rahul Ramaswamy, Ronni Wasmuth

Haematologica· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis